Incidences of overall and site specific cancers in TNF[alpha] inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry.

MLA

Dreyer L, et al. “Incidences of Overall and Site Specific Cancers in TNF[Alpha] Inhibitor Treated Patients with Rheumatoid Arthritis and Other Arthritides - a Follow-up Study from the DANBIO Registry.” Annals of the Rheumatic Diseases, vol. 72, no. 1, Jan. 2013, pp. 79–82. EBSCOhost, https://doi.org/10.1136/annrheumdis-2012-201969.

APA

Dreyer L, Mellemkjær L, Andersen AR, Bennett P, Poulsen UE, Juulsgaard Ellingsen T, Hansen TH, Jensen DV, Linde L, Lindegaard HM, Loft AG, Nordin H, Omerovic E, Rasmussen C, Schlemmer A, Tarp U, & Hetland ML. (2013). Incidences of overall and site specific cancers in TNF[alpha] inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry. Annals of the Rheumatic Diseases, 72(1), 79–82. https://doi.org/10.1136/annrheumdis-2012-201969

Chicago

Dreyer L, Mellemkjær L, Andersen AR, Bennett P, Poulsen UE, Juulsgaard Ellingsen T, Hansen TH, et al. 2013. “Incidences of Overall and Site Specific Cancers in TNF[Alpha] Inhibitor Treated Patients with Rheumatoid Arthritis and Other Arthritides - a Follow-up Study from the DANBIO Registry.” Annals of the Rheumatic Diseases 72 (1): 79–82. doi:10.1136/annrheumdis-2012-201969.